These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 32869655

  • 1. Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.
    Faust L, Klowak M, MacRae C, Kopalakrishnan S, Showler AJ, Boggild AK.
    J Cutan Med Surg; 2021; 25(1):45-52. PubMed ID: 32869655
    [Abstract] [Full Text] [Related]

  • 2. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
    Lazo-Porras M, Prutsky GJ, Barrionuevo P, Tapia JC, Ugarte-Gil C, Ponce OJ, Acuña-Villaorduña A, Domecq JP, De la Cruz-Luque C, Prokop LJ, Málaga G.
    BMC Infect Dis; 2020 Jan 20; 20(1):62. PubMed ID: 31959113
    [Abstract] [Full Text] [Related]

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar 20; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A, Girdhar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2015 Mar 20; 81(4):356-62. PubMed ID: 26144850
    [Abstract] [Full Text] [Related]

  • 5. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun 20; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 6. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
    Cunha Mda G, Virmond M, Schettini AP, Cruz RC, Ura S, Ghuidella C, Viana Fdos R, Avelleira JC, Campos AA, Filho B.
    Lepr Rev; 2012 Sep 20; 83(3):261-8. PubMed ID: 23356027
    [Abstract] [Full Text] [Related]

  • 7. A rare variant of erythema nodosum leprosum: a case report.
    Dave S, Thappa DM, Nori AV, Jayanthi S.
    Dermatol Online J; 2003 Dec 20; 9(5):11. PubMed ID: 14996384
    [Abstract] [Full Text] [Related]

  • 8. Ofloxacin-containing combined drug regimens in the treatment of lepromatous leprosy.
    Rao PS, Ramachandran A, Sekar B, Ravi S, Subramanian M.
    Lepr Rev; 1994 Sep 20; 65(3):181-9. PubMed ID: 8942149
    [Abstract] [Full Text] [Related]

  • 9. Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil.
    Maia MV, Cunha Mda G, Cunha CS.
    An Bras Dermatol; 2013 Sep 20; 88(2):205-10. PubMed ID: 23739719
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
    Balagon MF, Cellona RV, Abalos RM, Gelber RH, Saunderson PR.
    Lepr Rev; 2010 Mar 20; 81(1):27-33. PubMed ID: 20496567
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P, Nagaraju B, Selvaraj V, Balasubramanyam S, Mahalingam VN, Mehendale SM, Pannikar VK, Gupte MD, Team of Study Investigators.
    Indian J Lepr; 2012 Mar 20; 84(3):195-207. PubMed ID: 23484334
    [Abstract] [Full Text] [Related]

  • 12. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M, Saunderson PR, Gelber RH.
    Lepr Rev; 2011 Sep 20; 82(3):213-21. PubMed ID: 22125929
    [Abstract] [Full Text] [Related]

  • 13. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
    Nery JA, Vieira LM, de Matos HJ, Gallo ME, Sarno EN.
    Rev Inst Med Trop Sao Paulo; 1998 Sep 20; 40(6):363-70. PubMed ID: 10436656
    [Abstract] [Full Text] [Related]

  • 14. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun 20; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

  • 15. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Hungria EM, Oliveira RM, Penna GO, Aderaldo LC, Pontes MA, Cruz R, Gonçalves HS, Penna ML, Kerr LR, Stefani MM, Bührer-Sékula S.
    Infect Dis Poverty; 2016 Dec 06; 5(1):110. PubMed ID: 27919284
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for erythema nodosum leprosum.
    Manandhar R, LeMaster JW, Roche PW.
    Int J Lepr Other Mycobact Dis; 1999 Sep 06; 67(3):270-8. PubMed ID: 10575406
    [Abstract] [Full Text] [Related]

  • 17. High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
    Ji B, Jamet P, Sow S, Perani EG, Traore I, Grosset JH.
    Antimicrob Agents Chemother; 1997 Sep 06; 41(9):1953-6. PubMed ID: 9303392
    [Abstract] [Full Text] [Related]

  • 18. Late relapses in leprosy patients in Brazil: 10-year post-trial of uniform multidrug therapy (U-MDT/CT-BR).
    Penna GO, Pontes MAA, Talhari S, Gonçalves HS, Talhari C, Pessoa AS, Pedroza V, Bührer-Sékula S, Stefani MMA, Penna MLF.
    Braz J Infect Dis; 2024 Sep 06; 28(2):103745. PubMed ID: 38697216
    [Abstract] [Full Text] [Related]

  • 19. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
    Ozturk Z, Tatliparmak A.
    Dermatol Ther; 2017 Jan 06; 30(1):. PubMed ID: 27549245
    [Abstract] [Full Text] [Related]

  • 20. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP, Malta AM, Sarno EN, Kaplan G.
    Int J Lepr Other Mycobact Dis; 1996 Sep 06; 64(3):268-73. PubMed ID: 8862260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.